Nasdaq

Biosense Webster Receives FDA Approval for THERMOCOOL SMARTTOUCH® SF Ablation Catheter for the Treatment of Persistent Atrial Fibrillation

The CARTO® 3 System and THERMOCOOL SMARTTOUCH® SF Catheter allow for a patient-tailored ablation approach, resulting in high long-term effectiveness in persistent atrial fibrillation patients* IRVINE, ...
Business Wire

Biosense Webster Successfully Completes First Clinical Atrial Fibrillation Ablation Cases in the European Union Using the THERMOCOOL ® SMARTTOUCH™ Contact Force Sensing Catheter

DIAMOND BAR, Calif.--(BUSINESS WIRE)--Biosense Webster, Inc., a Johnson & Johnson company, and a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced the successful ...
Nasdaq

Biosense Webster Presents Late-Breaking Data from inspIRE and admIRE Clinical Trials at AF Symposium

IRVINE, Calif., Feb. 2, 2024 /PRNewswire/ -- Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced 12-month results from the company ...
AOL

Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety an

Biosense Webster Reports Compelling Results from Ground-Breaking SMART-AF IDE Study on the Safety and Effectiveness of the THERMOCOOL®SMARTTOUCH™Catheter THERMOCOOL® SMARTTOUCH™ Catheter and Software ...
FiercePharma

Biosense Webster Enrolls First Patient in Groundbreaking SMART-AF Trial

Completes First Atrial Fibrillation Ablation Case in the United States Using The THERMOCOOL ® SMARTTOUCH ™ Contact Force Sensing Catheter & Software Module DIAMOND BAR, Calif.--(BUSINESS WIRE)-- ...
News Medical

Biosense Webster enrolls and treats first AF patient in clinical study of new RF balloon catheter

Multicenter Study to Evaluate Balloon Ablation Catheter for Safety and Effectiveness in Achieving Pulmonary Vein Isolation in Treatment of Paroxysmal Atrial Fibrillation Johnson & Johnson Medical ...
Seeking Alpha

Biosense Webster Launches New Version of CARTO™ 3 Electro-Anatomical Mapping System

Increases efficiency, reproducibility, and accuracy i in the electro-anatomical maps electrophysiologists use in catheter ablation procedures IRVINE, Calif., May 8, 2024 /PRNewswire/ -- Biosense ...
News Medical

Biosense Webster enrolls and treats first patient in QDOT AF study

Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, a worldwide leader in the diagnosis and treatment of heart arrhythmias, has enrolled and treated the first patient in ...
TCTMD

Biosense Webster Announces Initial Results From First In-Human Study Of Novel High Power-Short Duration Ablation Catheter For Atrial Fibrillation

SAN FRANCISCO – Johnson & Johnson Medical Devices Companies* today announced that Biosense Webster, Inc.’s QDOT MICRO, a novel catheter that facilitates high power-short duration radiofrequency (RF) ...
PharmiWeb

Biosense Webster Launches the OPTRELL™ Mapping Catheter with TRUEref™ Technology for Mapping of Complex Cardiac Arrhythmias

Industry’s highest density fixed array mapping catheter, covering the largest area in a fixed matrix format, can help physicians effectively map in a shorter procedure time IRVINE, CA – July 24, 2023 ...
FiercePharma

Biosense Webster Successfully Completes First Clinical Atrial Fibrillation Ablation Cases in the European Union Using the

THERMOCOOL ® SMARTTOUCH™ Catheter from Biosense Webster Enables Contact Force Sensing in the Ablation of Atrial Fibrillation “THERMOCOOL ® SMARTTOUCH ™ Catheter brings new force reading information to ...